Clinical Trial Update: Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Endostar and/or Cisplatin for malignant pleural effusion or ascites has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites
• Malignant Pleural Effusion

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Malignant Pleural Effusion, Malignant Ascites | Phase 2 | Status: COMPLETED